Zicam expands lineup with cold remedy for kids
Matrixx Initiatives Inc. has introduced Zicam Kids, a homeopathic cold medicine designed to provide symptom relief for children ages 6 to 11.
Supplier News
PrescribeWellness Walgreens license
PrescribeWellness Takes Steps to Ensure Medication Synchronization Tools Are Available to All of Its Pharmacy Customers November 18, 2014 09:06 AM Eastern Standard Time ALISO VIEJO, Calif.
Hershey premieres new ‘Candy Experience’ at Winn-Dixie
A new retail concept from The Hershey Co. made its debut at food and drug retailer Winn-Dixie. Hershey’s "Candy Experience" concept brings the candy aisle into the front of Winn-Dixie’s Baton Rouge store.
Topical BioMedics unveils new Topricin display
Topical BioMedics Inc. has introduced a new Topricin floor display for retailers. The company said Wednesday that the four-color unit sports a small footprint yet holds multiple combinations of any Topricin topical pain relief formula and size, providing maximum flexibility, exposure and sales.
Emdeon to acquire Change Healthcare
Emdeon Inc. has entered into an agreement to acquire Change Healthcare, a provider of health care consumer engagement and transparency solutions Emdeon, a Nashville, Tenn.
Longtime Energizer executive Martire to retire
Veteran Energizer Holdings Inc. executive Lou Martire plans to retire next year after more than four decades at the company.
Pfizer ships Trumenba meningitis vaccine
Pfizer Inc. has released Trumenba, a meningococcal group B vaccine, to pharmacies and other health care providers in the United States.
Lannett chief compliance officer to retire
Pharmaceutical industry veteran Ernest Sabo plans to retire from Lannett Co. next year. The generic pharmaceutical company said late Monday that Sabo, vice president of regulatory affairs and chief compliance officer, is slated to retire effective Jan. 2, 2015.
Teva Canada launches Celebrex generic
Teva Canada Ltd. has released a generic version of Pfizer Inc.’s arthritis pain drug Celebrex (celecoxib). Teva said Monday that its generic celecoxib product, approved by Health Canada, is available now in pharmacies across Canada.
Revlon adds tagline in global brand relaunch
Cosmetics and beauty care giant Revlon Inc. has relaunched its brand with a global tagline, its first in more than a decade.
P&G executive named to chair CHPA
Patrick Lockwood-Taylor, vice president of personal health care for North America and digestive wellness design at Procter & Gamble Co., has been elected as chairman of the Consumer Healthcare Products Association (CHPA).
Cetaphil updates labeling for RestoraDerm line
Galderma Laboratories has unveiled a new look for its Cetaphil RestoraDerm line of eczema-soothing products.
Actavis acquires Allergan
Actavis PLC is acquiring Allergan Inc. in a transaction valued at about $66 billion. The combination will create one of the top-10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23 billion anticipated in 2015.
FDA informs Kremers Urban of ADHD drug reclassification
The Food and Drug Administration is reclassifying methylphenidate hydrochloride extended-release tablets from Kremers Urban Pharmaceuticals Inc. as the agency seeks more bioequivalence information.
Berkshire Hathaway to buy Procter & Gamble’s Duracell
Conglomerate Berkshire Hathaway Inc. has agreed to acquire the Duracell battery business from Procter & Gamble Co. The companies said Thursday that the deal, encompassing roughly $6.
Telehealth provider HealthSpot draws investment from Xerox
Information and imaging technology giant Xerox is making an investment in telehealth provider HealthSpot Inc.